VOLITIONRX LTD — Director's Dealing 2016

Oct 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-10-05

Reporting Person: KRATOCHVIL DAVID MATTHEW (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-05	Common Stock	P	10000	$5	Acquired	10000	Direct

Footnotes

F1: These shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on October 5, 2016. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriters.